Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FormidableMD vs Medro

FormidableMD
Graded #71

Higher grade

vs+9.600000000000001
Medro
Graded #252

Lower grade

The verdict

FormidableMD takes it — 73.2/100 to 63.6/100.

FormidableMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormidableMD is a physician-led, cash-pay telehealth practice based in Florida offering GLP-1 weight-loss treatment — semaglutide and tirzepatide in both FDA-approved and compounded forms, plus oral options…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFormidableMD +6
56
50
Dose & formulationFormidableMD +1
78
77
Clinical oversightFormidableMD +17
88
71
Labs & monitoringFormidableMD +31
83
52
FulfillmentMedro +20
72
92
Contract termsFormidableMD +28
61
33
FormidableMD · left barMedro · right bar

The numbers

MetricFormidableMDMedro
WeighScore73.2/10063.6/100
GradeCC
Scorecard rank#71#252
Semaglutide$169/mo (1 mg dose, compounded)$199/mo (compounded)
Tirzepatide$199/mo (10 mg dose, compounded)$299/mo (compounded)
Coverage1 stateAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
FormidableMD

Graded #71 · C

Strengths

  • Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
  • Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
  • Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible

Where it loses points

  • Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
  • Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
  • The 503A compounding pharmacy partner is not named on the site
Medro

Graded #252 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard